Cargando…
Ebselen, a new candidate therapeutic against SARS-CoV-2
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
IJS Publishing Group Ltd. Published by Elsevier Ltd.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7583587/ https://www.ncbi.nlm.nih.gov/pubmed/33120196 http://dx.doi.org/10.1016/j.ijsu.2020.10.018 |
| _version_ | 1783599421994303488 |
|---|---|
| author | Haritha, C.V. Sharun, Khan Jose, Bosco |
| author_facet | Haritha, C.V. Sharun, Khan Jose, Bosco |
| author_sort | Haritha, C.V. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7583587 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | IJS Publishing Group Ltd. Published by Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-75835872020-10-26 Ebselen, a new candidate therapeutic against SARS-CoV-2 Haritha, C.V. Sharun, Khan Jose, Bosco Int J Surg Correspondence IJS Publishing Group Ltd. Published by Elsevier Ltd. 2020-12 2020-10-23 /pmc/articles/PMC7583587/ /pubmed/33120196 http://dx.doi.org/10.1016/j.ijsu.2020.10.018 Text en © 2020 IJS Publishing Group Ltd. Published by Elsevier Ltd. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Correspondence Haritha, C.V. Sharun, Khan Jose, Bosco Ebselen, a new candidate therapeutic against SARS-CoV-2 |
| title | Ebselen, a new candidate therapeutic against SARS-CoV-2 |
| title_full | Ebselen, a new candidate therapeutic against SARS-CoV-2 |
| title_fullStr | Ebselen, a new candidate therapeutic against SARS-CoV-2 |
| title_full_unstemmed | Ebselen, a new candidate therapeutic against SARS-CoV-2 |
| title_short | Ebselen, a new candidate therapeutic against SARS-CoV-2 |
| title_sort | ebselen, a new candidate therapeutic against sars-cov-2 |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7583587/ https://www.ncbi.nlm.nih.gov/pubmed/33120196 http://dx.doi.org/10.1016/j.ijsu.2020.10.018 |
| work_keys_str_mv | AT harithacv ebselenanewcandidatetherapeuticagainstsarscov2 AT sharunkhan ebselenanewcandidatetherapeuticagainstsarscov2 AT josebosco ebselenanewcandidatetherapeuticagainstsarscov2 |